Tag

NASDAQ: AGEN

Agenus details first BOT+BAL approvals ahead of Phase 3 start
Adrian Kessler · Nov 5, 2026
The next front against cancer: A Mugglehead roundup
Joseph Morton · Dec 24, 2025